{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:27:43Z","timestamp":1794565663790,"version":"4.9.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"vor","delay-in-days":5576,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1111\/j.1538-7836.2007.02666.x","type":"journal-article","created":{"date-parts":[[2007,8,17]],"date-time":"2007-08-17T20:25:32Z","timestamp":1187382332000},"page":"1914-1922","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Challenges in defining type 2M von Willebrand disease: results from a Canadian cohort study"],"prefix":"10.1016","volume":"5","author":[{"given":"P.D.","family":"JAMES","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"NOTLEY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"HEGADORN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.\u2010C.","family":"POON","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"WALKER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"RAPSON","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"LILLICRAP","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2007.02666.x_bb0010","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1055\/s-0038-1642722","article-title":"The role of von Willebrand factor and fibrinogen in the initiation of platelet adhesion to thrombogenic surfaces","volume":"74","author":"Ruggeri","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02666.x_bb0015","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood.V69.2.454.454","article-title":"Epidemiological investigation of the prevalence of von Willebrand\u2019s disease","volume":"69","author":"Rodeghiero","year":"1987","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2007.02666.x_bb0020","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0022-3476(05)80384-1","article-title":"Prevalence of von Willebrand disease in children: a multiethnic study","volume":"123","author":"Werner","year":"1993","journal-title":"J Pediatr"},{"key":"10.1111\/j.1538-7836.2007.02666.x_bb0025","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor","volume":"4","author":"Sadler","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02666.x_bb0030","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0092-8674(85)90060-1","article-title":"Molecular cloning of cDNA for human von Willebrand factor: authentication by a new method","volume":"41","author":"Lynch","year":"1985","journal-title":"Cell"},{"key":"10.1111\/j.1538-7836.2007.02666.x_bb0035","doi-asserted-by":"crossref","first-page":"6394","DOI":"10.1073\/pnas.82.19.6394","article-title":"Cloning and characterization of two cDNAs coding for human von Willebrand factor","volume":"82","author":"Sadler","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1538-7836.2007.02666.x_bb0040","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1126\/science.3874428","article-title":"Human von Willebrand factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localization","volume":"228","author":"Ginsburg","year":"1985","journal-title":"Science"},{"key":"10.1111\/j.1538-7836.2007.02666.x_bb0045","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1002\/j.1460-2075.1986.tb04435.x","article-title":"Full\u2010length von Willebrand factor (vWF) cDNA encodes a highly repetitive protein considerably larger than the mature vWF subunit","volume":"5","author":"Verweij","year":"1986","journal-title":"EMBO J"},{"key":"10.1111\/j.1538-7836.2007.02666.x_bb0050","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1055\/s-0038-1651576","article-title":"von Willebrand disease: a database of point mutations, insertions, and deletions","volume":"69","author":"Ginsburg","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02666.x_bb0055","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1182\/blood.V88.7.2559.bloodjournal8872559","article-title":"Type 2M:Milwaukee\u20101 von Willebrand disease: an in\u2010frame deletion in the Cys509\u2010Cys695 loop of the von Willebrand factor A1 domain causes deficient binding of von Willebrand factor to platelets","volume":"88","author":"Mancuso","year":"1996","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2007.02666.x_bb0060","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1053\/beha.2001.0134","article-title":"A molecular approach to the classification of von Willebrand disease","volume":"14","author":"Schneppenheim","year":"2001","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1111\/j.1538-7836.2007.02666.x_bb0065","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1055\/s-0037-1613995","article-title":"Type 2M vWD resulting from a lysine deletion within a four lysine residue repeat in the A1 loop of von Willebrand factor","volume":"84","author":"Hilbert","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02666.x_bb0070","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1055\/s-0037-1613060","article-title":"Identification of a new type 2M von Willebrand disease mutation also at position 1324 of von Willebrand factor","volume":"87","author":"Hilbert","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02666.x_bb0075","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1055\/s-0037-1616142","article-title":"Ser968Thr mutation within the A3 domain of von Willebrand factor (VWF) in two related patients leads to a defective binding of VWF to collagen","volume":"86","author":"Ribba","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02666.x_bb0080","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1182\/blood-2006-05-021105","article-title":"The mutational spectrum of type 1 von Willebrand disease: results from a Canadian cohort study","volume":"109","author":"James","year":"2007","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2007.02666.x_bb0085","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1182\/blood-2006-05-020784","article-title":"Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM\u20101VWD)","volume":"109","author":"Goodeve","year":"2007","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2007.02666.x_bb0090","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1160\/TH06-07-0383","article-title":"An investigation of the von Willebrand factor genotype in UK patients diagnosed to have type 1 von Willebrand disease","volume":"96","author":"Cumming","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02666.x_bb0095","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1182\/blood-2003-06-2072","article-title":"Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study","volume":"103","author":"Federici","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2007.02666.x_bb0100","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1055\/s-2006-949661","article-title":"Diagnosis of inherited von Willebrand disease: a clinical perspective","volume":"32","author":"Federici","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/j.1538-7836.2007.02666.x_bb0105","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1182\/blood.V91.5.1572","article-title":"Type 2M von Willebrand disease: F606I and I662F mutations in the glycoprotein Ib binding domain selectively impair ristocetin\u2010 but not botrocetin\u2010mediated binding of von Willebrand factor to platelets","volume":"91","author":"Hillery","year":"1998","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2007.02666.x_bb0110","unstructured":"Clinical and Laboratory Standards Institute (formerly NCCLS). Assays of von Willebrand Factor Antigen and Ristocetin Cofactor Activity; Approved Guideline. H51\u2010A 22, Number 20. CLSI, 2002."},{"key":"10.1111\/j.1538-7836.2007.02666.x_bb0115","first-page":"215","article-title":"A one\u2010stage factor VIII (antihaemophilic globulin) assay and its use on venous and capillary plasma","volume":"7","author":"Hardisty","year":"1962","journal-title":"Thromb Diath Haemorrh"},{"key":"10.1111\/j.1538-7836.2007.02666.x_bb0120","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1055\/s-0038-1645215","article-title":"Luminographic detection of von Willebrand factor multimers in agarose gels and on nitrocellulose membranes","volume":"63","author":"Budde","year":"1990","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02666.x_bb0125","doi-asserted-by":"crossref","first-page":"5444","DOI":"10.1093\/nar\/19.19.5444","article-title":"A rapid non\u2010enzymatic method for the preparation of HMW DNA from blood for RFLP studies","volume":"19","author":"Lahiri","year":"1991","journal-title":"Nucleic Acids Res"},{"key":"10.1111\/j.1538-7836.2007.02666.x_bb0130","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1182\/blood.V66.6.1423.1423","article-title":"High\u2010resolution analysis of von Willebrand factor multimeric composition defines a new variant of type I von Willebrand disease with aberrant structure but presence of all size multimers (type IC)","volume":"66","author":"Ciavarella","year":"1985","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2007.02666.x_bb0135","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1182\/blood-2006-04-015065","article-title":"Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival","volume":"108","author":"Haberichter","year":"2006","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2007.02666.x_bb0140","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1055\/s-0038-1648458","article-title":"von Willebrand disease masquerading as haemophilia A","volume":"67","author":"Mazurier","year":"1992","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02666.x_bb0145","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1182\/blood.V97.4.952","volume":"97","author":"Ribba","year":"2001","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2007.02666.x_bb0150","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1538-7836.2006.01860.x","article-title":"Genetic linkage and association analysis in type 1 von Willebrand disease: results from the Canadian type 1 VWD study","volume":"4","author":"James","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02666.x_bb0155","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood.V69.6.1691.1691","article-title":"The effect of ABO blood group on the diagnosis of von Willebrand disease","volume":"69","author":"Gill","year":"1987","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2007.02666.x_bb0160","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1046\/j.1365-2141.2002.03199.x","article-title":"Use of the collagen\u2010binding assay for von Willebrand factor in the analysis of type 2M von Willebrand disease: a comparison with the ristocetin cofactor assay","volume":"116","author":"Riddell","year":"2002","journal-title":"Br J Haematol"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2007.02666.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622102953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622102953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2007.02666.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:43:02Z","timestamp":1761532982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622102953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S1538783622102953"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02666.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenges in defining type 2M von Willebrand disease: results from a Canadian cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02666.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}